Blanket Purchase Agreement V797D70090-15BNAS26A00000038

Quest Diagnostics Incorporated, a major clinical laboratory testing and diagnostic information services provider headquartered in Secaucus, New Jersey, was awarded a single-award Blanket Purchase Agreement valued at $17.4 million by a Civilian federal agency through the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). This bridge contract, effective April 1, 2026, through June 30, 2026, was established to provide laboratory testing and diagnostic services covering the January through March 2026 service period. The contract carries no set-aside designation, reflecting Quest Diagnostics' competitive positioning in the open federal marketplace. As the prime contractor under this indefinite delivery vehicle, Quest Diagnostics will deliver comprehensive medical diagnostic solutions consistent with its established service portfolio.

Under this agreement, Quest Diagnostics will provide a full range of clinical laboratory testing, medical diagnostic analysis, and reference laboratory services to support the federal agency's healthcare operations. Based on the company's historical federal contract performance, deliverables are expected to include specialized diagnostic screening, infectious disease testing, genetic and esoteric laboratory analysis, and other clinical laboratory services. The contract structure as a Blanket Purchase Agreement allows the agency to issue individual task orders for specific testing requirements as needs arise, leveraging Quest Diagnostics' extensive experience in providing similar services to other federal agencies, particularly the Department of Veterans Affairs through multiple Veterans Integrated Service Networks. The $17.4 million ceiling value provides substantial procurement flexibility for the funding agency to address its diagnostic testing requirements through the contract period.